NASDAQ · Price History

BillionToOne, Inc. (BLLN) Stock Price History & Returns

$97.50 NASDAQ: BLLN Market Cap $4.66B

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How BillionToOne, Inc. (BLLN) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $97.50 sits 40% of the way up a 52-week range of $61.96 to $150.44; 35.2% below the 52-week high; below its 50-day moving average of $106.23; above its 200-day average of $97.29; a beta of 0.34 means it has historically moved less than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months+12.7%
6 months+27.3%
1 year+17.4%

Year by year

1 of 1 years closed higher than the year before. Closes are the last observation in each calendar year.

YearCloseChange
2026$97.50+19.1%

Monthly closing prices

The last 13 months, newest first. 7 of 12 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$97.50-14.0%
October 2026$113.32+6.5%
September 2026$106.44+17.4%
August 2026$90.67-34.6%
July 2026$138.60+15.5%
June 2026$119.98+21.2%
May 2026$98.99+31.9%
April 2026$75.05-4.9%
March 2026$78.94+3.4%
February 2026$76.33-7.5%
January 2026$82.51+0.8%
December 2025$81.84-37.1%
November 2025$130.18—

BillionToOne, Inc. (BLLN) price history — frequently asked questions

How has BillionToOne, Inc. performed over the last year?

BillionToOne, Inc. (BLLN) has risen 17.4% over the last twelve months, measured on price alone.

What is BillionToOne, Inc.'s five-year return?

Over five years the BLLN share price has gained 0.0%, excluding dividends.

What is BillionToOne, Inc.'s 52-week range?

Over the last year BillionToOne, Inc. (BLLN) has traded between $61.96 and $150.44.

Price returns of other Medical - Diagnostics & Research stocks

TMO 1-year +21.1%DHR 1-year +6.1%IDXX 1-year +3.3%A 1-year +19.3%WAT 1-year +18.8%IQV 1-year +18.6%NTRA 1-year +34.8%MTD 1-year +23.3%ILMN 1-year +72.6%LH 1-year +39.7%All Medical - Diagnostics & Research stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.